A company focused on the prediction and experimental evaluation of ADME and Pharmacokinetics for drug discovery.
Our mission is to discover, develop, and make available new treatments that meet unmet medical needs for people suffering from central nervous system (CNS) disorders.
A generic pharmaceutical research and development company.
Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies.
A player in the development of recombinant human lactoferrin (rhLF), is a biopharmaceutical company focused on developing protein-based drugs for oncology, asthma and wound healing.
Commercial contract research organization (CRO) providing low cost pre-clinical drug development services to biopharmaceutical companies (pharmicological screening and acute toxicology).
AME's mission is to be the world leader in directed evolution, delivering superior value to patients, employees, collaborators and stockholders by discovering, developing and commercializing optimized human biotherapeutics.
A research-oriented biotechnology company gaining new insights into ORIgins of DISeases with genomic and proteomic investigation of human diseased tissues. The company will develop new diagnostic and therapeutic targets and substances.
Specializes in pharmaceutical research, development and manufacturing of diabetes treatment drug DIAB II, also known as Sucanon, a new drug for the treatment of type 2 diabetes
Virinova has developed a novel virus diagnostic technology for process control and diagnostic monitoring of viral infections. No antibodies or PCR is required and the method is suitable for all virus types including unknown viruses. It allows the direct detection of virus particles in minutes.
|